Registration - Consultant

JN Nova Pharma Inc. / Stephen Sampson, Consultant

Registration Information

Client name: JN Nova Pharma Inc.
Lobbyist name: Stephen Sampson, Consultant
Initial registration start date: 2023-10-16
Registration status: Active
Registration Number: 814311-376117

Associated Communications

Total Number of Communication Reports: 3

Monthly communication reports in the last 6 months: 3

Version 2 of 2 (2024-02-01 to present)

Lobbying Information

Subject Matters

Health
Industry
Intellectual Property
Research and Development
Science and Technology

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Funding opportunities for the research and development of therapeutics for unmet medical needs under the Strategic Innovation Fund and/or other similar programs.

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Finance Canada (FIN)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
National Research Council (NRC)
Senate of Canada

Client Details

Government funding

End date of the last completed financial year: 2023-12-31

List of Government Funding
Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
National Research Council (NRC)	$0.00	Yes

Client Contact Information

Address:
17002 Portobello Road
Ottawa, ON K4A 4W0
Canada

Telephone number: 647-622-2774
Web address: https://jnnova.com/

Client representative

Nathan Yoganathan, Chief Scientific Officer

Parent Company Information

JN Nova Pharma Inc. is not a subsidiary of any other parent companies.

Coalition Members Information

JN Nova Pharma Inc. is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of JN Nova Pharma Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

JN Nova Pharma Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Stephen Sampson | Public offices held

Business address:
50 O'Connor St., Suite 901
Ottawa, ON K1P 6L2
Canada

Telephone number: 613-782-2336

Consultant Firm and Address

Firm: Global Public Affairs

Address:
50 O'Connor St., Suite 901
Ottawa, ON K1P 6L2
Canada

Telephone number: 613-782-2336

JN Nova Pharma Inc./

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
JN Nova Pharma Inc./	2023-10-16	current

JN Nova Pharma Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Stephen Sampson, Global Public Affairs (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-3 of 3

JN Nova Pharma Inc.
Consultant: Stephen Sampson

Designated Public Office Holders who participated in the communication:
- Laurel Chester, Senior Advisor | Office of the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
- Simran Arulraj, Special Assistant | Office of the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Science and Technology
Communication date: 2024-02-12
Posted date: 2024-02-13
Communication number: 376117-592565 View associated registration
JN Nova Pharma Inc.
Consultant: Stephen Sampson

Designated Public Office Holders who participated in the communication:
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia, Director | Life Sciences Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Science and Technology
Communication date: 2024-02-12
Posted date: 2024-02-13
Communication number: 376117-592561 View associated registration
JN Nova Pharma Inc.
Consultant: Stephen Sampson

Designated Public Office Holders who participated in the communication:
- Marie-France Lalonde, Member of Parliament | House of Commons
- Mahdi Ellorhaoui, Member's Assistant | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Science and Technology
Communication date: 2023-12-14
Posted date: 2023-12-15
Communication number: 376117-588312 View associated registration

Stephen Sampson, Global Public Affairs (Consultant)

Learn more...

Results below are sorted by posted date, beginning with the most recent.

Results 1-3 of 3

JN Nova Pharma Inc.
Consultant: Stephen Sampson

Designated Public Office Holders who participated in the communication:
- Laurel Chester, Senior Advisor | Office of the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
- Simran Arulraj, Special Assistant | Office of the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Science and Technology
Communication date: 2024-02-12
Posted date: 2024-02-13
Communication number: 376117-592565 View associated registration
JN Nova Pharma Inc.
Consultant: Stephen Sampson

Designated Public Office Holders who participated in the communication:
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia, Director | Life Sciences Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Science and Technology
Communication date: 2024-02-12
Posted date: 2024-02-13
Communication number: 376117-592561 View associated registration
JN Nova Pharma Inc.
Consultant: Stephen Sampson

Designated Public Office Holders who participated in the communication:
- Marie-France Lalonde, Member of Parliament | House of Commons
- Mahdi Ellorhaoui, Member's Assistant | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Science and Technology
Communication date: 2023-12-14
Posted date: 2023-12-15
Communication number: 376117-588312 View associated registration

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Legislative Assistant Privy Council Office (PCO), Office of the Government House Leader	August 2004 to January 2006	Not a designated office
Special Assistant (Policy) Transport Canada, Office of the Minister of Transport	December 2003 to July 2004	Not a designated office
Executive Assistant House of Commons, Office of M.P. for Hamilton East - Stoney Creek	July 2001 to November 2003	Not a designated office
Legislative Assistant House of Commons, Office of M.P. for Hamilton Mountain	December 2000 to June 2001	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Legislative Assistant Privy Council Office (PCO), Office of the Government House Leader	August 2004 to January 2006	Not a designated office
Special Assistant (Policy) Transport Canada, Office of the Minister of Transport	December 2003 to July 2004	Not a designated office
Executive Assistant House of Commons, Office of M.P. for Hamilton East - Stoney Creek	July 2001 to November 2003	Not a designated office
Legislative Assistant House of Commons, Office of M.P. for Hamilton Mountain	December 2000 to June 2001	Not a designated office

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

JN Nova Pharma Inc. / Stephen Sampson, Consultant

Registration Information

Associated Communications

Version 2 of 2 (2024-02-01 to present)

Version 2 of 2 (2024-02-01 to present)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address